Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-01-23
2011-12-13
Allen, Marianne P (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S324000, C530S327000, C530S330000, C514S009100, C514S021600, C514S021500, C514S021300
Reexamination Certificate
active
08076300
ABSTRACT:
FGF2-binding peptides are here described, which have been designed starting from the N-terminal region of PTX3, in particular spanning the PTX3(82-11O) region. Synthetic peptides related to this sequence are able to bind FGF2and to inhibit its pro-angiogenic activity in vitro and in vivo with no anticipated impact on innate immunity.
REFERENCES:
patent: 2008/0015153 (2008-01-01), Bottazzi et al.
patent: WO 02/38169 (2002-05-01), None
patent: WO 03/072603 (2003-09-01), None
Marco Rusnati et al. “Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis” in Blood, Jul. 1, 2004, vol. 104, No. 1, pp. 92-99, ISSN: 0006-4971.
Marco Rusnati et al. “Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis” in Cytokine Growth Factor Reviews, Apr. 2005, pp. 159-178, ISSN: 1359-6101.
Catherine Perollet et al. “Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization” in Blood, vol. 91 No. 9, pp. 3289-3299, May 1, 1998, ISSN: 0006-4971.
Maura Camozzi et al. “Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivo” in Arteriosclerosis, Thrombosis, and Vascular Biology, pp. 1837-1842, Sep. 2005, ISSN: 1524-4636.
Maura Camozzi et al. “Identification of an antiangiogenic FGF-2binding site in the N terminus of the soluble pattern recognition receptor PTX3” in The Journal of Biological Chemistry, pp. 22605-22613, Aug. 11, 2006, ISSN: 0021-9258.
Camozzi Maura
Colombo Maurizio
Mastroianni Domenico
Presta Marco
Rusnati Marco
Allen Marianne P
Steinfl & Bruno LLP
Tecnogen S.p.A.
LandOfFree
FGF2-binding peptides and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with FGF2-binding peptides and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and FGF2-binding peptides and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4254190